Reconstitution of naïve T cells and type 1 function after autologous peripheral stem cell transplantation: impact on the relapse of original cancer

Background. Phenotypic and functional reconstitution of T cells after peripheral blood stem cell transplantation (PBSCT) and its influence on posttransplant immune status is important in terms of immune surveillance and relapse of original cancer. We investigated the relationship between the dominant immune reconstitution pathway and the immune surveillance. We also tested the cytokine bias acquired by T cells after transplantation and its possible influence on relapse of original malignancy. Methods. Immunophenotyping of naïve and memory T cells was performed by flow cytometry on patients who underwent PBSCT for various cancers. Cytokine production by peripheral memory helper (CD4) and cytotoxic (CD8) T cells was investigated at various pretransplant and posttransplant time points with fluorescein isothiocyanate–based intracellular cytokine assay after short-term in vitro mitogenic stimulation (phorbol myristate acetate + ionomycin). Data on T-cell subsets and polarized cytokines &ggr;-interferon (Ifn) and interleukin 4 produced by memory T cells were compared with that of healthy controls. Results. The reconstitution of naïve T cells and &ggr;-Ifn–producing memory cells was significantly lower in patients who experienced relapse of original cancer within 1 year of PBSCT compared to those who showed no signs of relapse even after 2 years and compared to normal subjects. The results indicate that efficient reconstitution of naïve T cells and type 1 function of memory T cells are important in maintaining T-cell repertoire diversity after PBSCT. It also confers appropriate levels of immune surveillance against diverse neoantigens that evolve from residual tumor burden. The data reveal that chemotherapy-induced thymic injuries may impair regeneration of naïve cells that result in a naivopenic state in a susceptible host. Conclusions. The study highlights the importance of naïve T-cell reconstitution and points towards cell replacement strategies for improving immune surveillance after PBSCT.

[1]  R. McKay,et al.  Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.

[2]  D. Neuberg,et al.  Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism , 2000 .

[3]  S. Rana,et al.  Antioxidative enzymes in the liver and kidney of alloxan induced diabetic rats and their implications in cadmium toxicity. , 2000, Physiological chemistry and physics and medical NMR.

[4]  T. Zwillich.  Diabetes research. Islet transplants not yet ready for prime time. , 2000, Science.

[5]  D. Neuberg,et al.  Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. , 2000, Blood.

[6]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .

[7]  M. Roederer,et al.  Differential representations of memory T cell subsets are characteristic of polarized immunity in leprosy and atopic diseases. , 1999, International immunology.

[8]  R. Koup,et al.  Generation of functional thymocytes in the human adult. , 1999, Immunity.

[9]  I. Cohen,et al.  The pathogenicity of islet‐infiltrating lymphocytes in the non‐obese diabetic (NOD) mouse , 1999, Clinical and experimental immunology.

[10]  Danhong Lu,et al.  A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. , 1999, The Journal of clinical investigation.

[11]  M. Salmon,et al.  IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. , 1998, Journal of immunology.

[12]  A. Koizumi,et al.  Mapping of murine diabetogenic gene mody on chromosome 7 at D7Mit258 and its involvement in pancreatic islet and beta cell development during the perinatal period. , 1998, The Journal of clinical investigation.

[13]  B. Tobin,et al.  Pancreatic islet transplantation, but not intensive insulin therapy, corrects the pulmonary vascular complications of streptozotocin diabetes. , 1998, Canadian journal of physiology and pharmacology.

[14]  D. Umetsu,et al.  T helper 2-dominant antilymphoma immune response is associated with fatal outcome. , 1997, Blood.

[15]  K. Weinberg,et al.  Immunological reconstitution following bone marrow transplantation , 1997, Immunological reviews.

[16]  Masato Yoshioka,et al.  A Novel Locus, Mody4, Distal to D7Mit189 on Chromosome 7 Determines Early-Onset NIDDM in Nonobese C57BL/6 (Akita) Mutant Mice , 1997, Diabetes.

[17]  R. Gress,et al.  Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL. , 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  M. Stegall,et al.  Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody. , 1996, The Journal of surgical research.

[19]  M. Roederer,et al.  CD8 naive T cell counts decrease progressively in HIV-infected adults. , 1995, The Journal of clinical investigation.

[20]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[21]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[22]  N. Di Paolo,et al.  Fetal thymic transplant in patients with Hodgkin's disease. , 1973, Blood.